Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

414 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical role of positron emission tomography in oncology.
Bomanji JB, Costa DC, Ell PJ. Bomanji JB, et al. Lancet Oncol. 2001 Mar;2(3):157-64. doi: 10.1016/s1470-2045(00)00257-6. Lancet Oncol. 2001. PMID: 11902566 Review.
Emission computerised tomography. A new diagnostic imaging technique.
Ell PJ, Jarritt PH, Deacon J, Brown NJ, Williams ES. Ell PJ, et al. Lancet. 1978 Sep 16;2(8090):608-10. doi: 10.1016/s0140-6736(78)92827-1. Lancet. 1978. PMID: 80530 No abstract available.
The role of PET imaging in lymphoma.
Burton C, Ell P, Linch D. Burton C, et al. Br J Haematol. 2004 Sep;126(6):772-84. doi: 10.1111/j.1365-2141.2004.05069.x. Br J Haematol. 2004. PMID: 15352980 Review.
The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery.
Rathore C, Dickson JC, Teotónio R, Ell P, Duncan JS. Rathore C, et al. Epilepsy Res. 2014 Oct;108(8):1306-14. doi: 10.1016/j.eplepsyres.2014.06.012. Epub 2014 Jul 7. Epilepsy Res. 2014. PMID: 25043753
Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.
Al-Nabhani KZ, Syed R, Michopoulou S, Alkalbani J, Afaq A, Panagiotidis E, O'Meara C, Groves A, Ell P, Bomanji J. Al-Nabhani KZ, et al. J Nucl Med. 2014 Jan;55(1):88-94. doi: 10.2967/jnumed.113.123547. Epub 2013 Dec 12. J Nucl Med. 2014. PMID: 24337608
The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation.
Goh V, Engledow A, Rodriguez-Justo M, Shastry M, Peck J, Blackman G, Endozo R, Taylor S, Halligan S, Ell P, Groves AM. Goh V, et al. J Nucl Med. 2012 May;53(5):687-92. doi: 10.2967/jnumed.111.098525. Epub 2012 Mar 27. J Nucl Med. 2012. PMID: 22454485 Clinical Trial.
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
Kayani I, Avril N, Bomanji J, Chowdhury S, Rockall A, Sahdev A, Nathan P, Wilson P, Shamash J, Sharpe K, Lim L, Dickson J, Ell P, Reynolds A, Powles T. Kayani I, et al. Clin Cancer Res. 2011 Sep 15;17(18):6021-8. doi: 10.1158/1078-0432.CCR-10-3309. Epub 2011 Jul 8. Clin Cancer Res. 2011. PMID: 21742806 Clinical Trial.
Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.
Begent J, Sebire NJ, Levitt G, Brock P, Jones KP, Ell P, Gordon I, Anderson J. Begent J, et al. Eur J Cancer. 2011 Feb;47(3):389-96. doi: 10.1016/j.ejca.2010.09.039. Epub 2010 Nov 10. Eur J Cancer. 2011. PMID: 21074411
18F-FDG PET and PET/CT in the evaluation of cancer treatment response.
Ben-Haim S, Ell P. Ben-Haim S, et al. J Nucl Med. 2009 Jan;50(1):88-99. doi: 10.2967/jnumed.108.054205. J Nucl Med. 2009. PMID: 19139187 Review.
414 results
Jump to page
Feedback